Ann: Update on the CardioCel 3D Product Launch, page-28

Well said.. with such a ground breaking product there is a lot to gain, Wayne isn't an idiot and he will do it once and do it right! It was also very interesting to see the recent sale of Cormatrix I bet that's because of the numerous issues they have had over the years with their products and now Admedus has the right management to capture market share with their superior product.

There is a good article in this weekend's AFR titled 'PROFIT FROM FUTURE MEGATRENDS' and two out of the four subjects covered Admedus would fall under Ageing: 'Average life expectancy in Australia is already 83 years and is projected to rise to 89 by 2050. But falling fertility rates are leading to lower population growth. So a far bigger chunk of the population is elderly - a phenomenon perhaps most acute in Japan, widespread across Europe and well under way in China where the one child policy has created it's own demographic quirks'.
'The obvious ways of playing the ageing theme are the healthcare and pharmaceutical industries'.

Urbanisation and rising middle classes: 'Both China and India are seeing a surging middle class, with China's growing from 5 million people 15 years ago to 225 million. This means rising demand for services like healthcare, leisure and tourism.'

With the ageing and rising middle class themes the market for our growing list of gold standard products is massive, global and also will continue to grow for decades to come.

GO ADMEDUS!